Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Leukemia & Lymphoma|August 1, 2002
The CD19 compartment in myeloma includes a population of clonal cells persistent after high-dose treatmentThomas Rasmussen, Linda Jensen, Hans Erik Johnsen
Ugeskrift for Laeger|June 24, 2008
[Complete remission after Rituximab treatment in refractory hairy cell leukemia]Irma Petruskevicius, Anne Bukh, Henrik Mertz, et al.
Leukemia & Lymphoma|September 14, 2004
In multiple myeloma clonotypic CD38- /CD19+ / CD27+ memory B cells recirculate through bone marrow, peripheral blood and lymph nodesThomas Rasmussen, Marianne Lodahl, Søren Hancke, et al.
Blood|February 11, 2003
Idiotype vaccination in multiple myeloma induced a reduction of circulating clonal tumor B cellsThomas Rasmussen, Lotta Hansson, Anders Osterborg, et al.
Experimental Hematology|February 2, 2002
Efficacy and safety of CD34-selected and CD19-depleted autografting in multiple myeloma patients: a pilot studyThomas Rasmussen, Bosse Björkstrand, Heidi Andersen, et al.
British Journal of Haematology|May 25, 2002
FGFR3 dysregulation in multiple myeloma: frequency and prognostic relevanceThomas Rasmussen, Heidi Rye Hudlebusch, Lene Meldgaard Knudsen, et al.
Annals of Hematology|April 19, 2005
Early changes in serum IL-6 and VEGF levels predict clinical outcome following first-line therapy in aggressive non-Hodgkin's lymphomaLars Møller Pedersen, Tobias Wirenfeldt Klausen, Ulla Høy Davidsen, et al.
Leukemia & Lymphoma|December 25, 2003
C-MAF oncogene dysregulation in multiple myeloma: frequency and biological relevanceThomas Rasmussen, Lene Meldgaard Knudsen, Inger Marie S Dahl, et al.
British Journal of Haematology|August 24, 2005
Identification of ID-1 as a potential target gene of MMSET in multiple myelomaHeidi Rye Hudlebusch, Kim Theilgaard-Mönch, Marianne Lodahl, et al.
European Heart Journal|July 11, 2006
Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart diseaseRasmus Sejersten Ripa, Yongzhong Wang, Erik Jørgensen, et al.
Pageof 7